C02KX01 |
B |
Bosentan (monohydrate) - 125mg |
5492 |
221726/08 |
TRACLEER |
125mg |
56 |
Tablet, film coated |
Oral |
Mersaco |
Haupt Pharma Wulfing GmbH |
Germany |
79,583,961 L.L |
2.44 |
E2 |
Actelion Pharmaceuticals Ltd |
Switzerland |
2/4/2025 |
|
C02KX01 |
B |
Bosentan (monohydrate) - 125mg |
11193 |
46522/1 |
TRACLEER |
125mg |
56 |
Tablet, film coated |
Oral |
Mersaco |
Haupt Pharma Wulfing GmbH |
Germany |
79,583,961 L.L |
2.44 |
E2 |
Janssen-Cilag AG |
Switzerland |
2/4/2025 |
|
C02KX01 |
G |
Bosentan (monohydrate) - 125mg |
9469 |
179417/1 |
BOSENTAN ARROW |
125mg |
56 |
Tablet, film coated |
Oral |
Darapharma S.A.L. |
APL Swift Services (Malta) Limited |
Malta |
46,880,685 L.L |
10.71 |
E1 |
Arrow Génériques |
France |
2/4/2025 |
|
C02KX01 |
G |
Bosentan (monohydrate) - 125mg |
8842 |
115416/1 |
PMS-BOSENTAN |
125mg |
60 |
Tablet |
Oral |
UPO S.A.L. |
Genvion Corporation |
Canada |
77,539,821 L.L |
10.71 |
E1 |
Pharmascience Inc |
Canada |
2/4/2025 |
|
C02KX01 |
G |
Bosentan (monohydrate) - 125mg |
9469/388 |
179417/1 |
BOSENTAN ARROW |
125mg |
56 |
Tablet, film coated |
Oral |
Darapharma S.A.L. |
APL Swift Services (Malta) Limited |
Malta |
L.L |
10.71 |
E1 |
Arrow Génériques |
France |
2/5/2024 |
|